← Eichor
Study identifier: NCT06660446 Synced from ClinicalTrials.gov · July 29, 2026
● Recruiting

Exercise During Chemotherapy Treatment As Adjuvant Program in Patients with Lymphoma: EDONOLA Study.

Condition: Lymphoma  ·  Sponsor: Biogipuzkoa Health Research Institute

PhaseNA
Planned participants180
Who can joinAll sexes, 18 Years to no upper limit
Healthy volunteersNo

About this study

In people diagnosed with lymphoma receiving immunochemotherapy treatment, a combined exercise intervention, as opposed to the general recommendations, will achieve: 1.Improve cardiorespiratory fitness, strength, psychological well-being and quality of life. //2.Reduce fatigue//3.Reduce frailty There is an association between some biological biomarkers with physical capacity and frailty.

This description comes directly from the study's public registry record.

Talk to the study team

Clinical Research Platform - Health Research Institut Biogipuzkoa  ·  +34943006140  ·  OSID.INVESTCLINICA@osakidetza.eus

Always discuss trial participation with your own doctor first.

Locations (3)

Hospital Universitario Araba (HUA)Vitoria - Gateiz, Araba, SpainNot Yet Recruiting
Hospital Universitario Galdakao (HUG)Galdakao, Bizkaia, SpainActive Not Recruiting
Hospital Universitario Donostia (HUD)San Sebastián, Guipuzcoa, SpainRecruiting

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT06660446